China’s Genuine Biotech nets $100m co-led by Efund Capital, and Yingke PE

China’s Genuine Biotech nets $100m co-led by Efund Capital, and Yingke PE

Photo: Pixabay

China’s Genuine Biotech has completed raising a $100 million Series B round, per a company statement on Friday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter